Minerva Biotechnologies

Exploring the Space between Stem Cells and Cancers

  • Cancer Therapeutics
  • Stems Cells & Reagents

Show me more

Latest Products

News

  • Minerva to Present at Needham & Company's 15th Annual Healthcare Conference

    Minerva to Present at Needham & Company’s 15th Annual Healthcare Conference

    Dr. Cynthia Bamdad, CEO and Founder of Minerva Biotechnologies, will be speaking at Needham and Company’s 15th Annual Healthcare Conference in New York City at 2pm on Wednesday, April 13th.  Her talk will take place in the Private Company Track of the conference.

    Read More

  • Minerva Discovers Naïve Stem Cell Growth Factor

    Minerva Discovers Naïve Stem Cell Growth Factor

    WALTHAM, Mass.–(BUSINESS WIRE)–Minerva Biotechnologies, a leading cancer and stem cell development company announces publication of their latest research article in the journal Stem Cells: “A Primitive Growth Factor, NME7-AB, Is Sufficient to Induce Stable Naïve State Human Pluripotency; Reprogramming in This Novel Growth Factor Confers Superior Differentiation” DOI: 10.1002/stem.2261. This article reports a major breakthrough […]

    Read More

  • BIO CEO and Investor Conference - Feb 8 and 9

    BIO CEO and Investor Conference – Feb 8 and 9

    Dr. Cynthia Bamdad, CEO and Founder of Minerva Biotechnologies will be speaking at the BIO CEO and Investor Conference in New York City on February 9th.  Her talk will take place in the Park North room at 9 AM.

    Read More